“…Previous studies have indicated that specific oligosaccharides can modulate multiple functions of intestinal epithelial cells, in vitro , in vivo and ex vivo (He et al., ; Holscher, Davis, & Tappenden, ; Kuntz et al., ; Kuntz, Kunz, & Rudloff, ; Newburg et al., ; Ortega‐Gonzalez et al., ; Zenhom et al., ). 3’‐sialyllactose and fructooligosaccharides were demonstrated to inhibit baseline chemokine expression and release from the Caco‐2 human intestinal cell line (Zenhom et al., ), while pooled HMOs and synthetic galactosyloligosaccharides were demonstrated to inhibit TNFα and salmonella induced chemokine release from human intestinal cell lines and immature intestinal tissue (Newburg et al., ), but did not appear to alter baseline levels. Similarly, 2’FL was demonstrated to inhibit E.coli induced IL‐8 release through a mechanism involving down‐regulation of the LPS receptor complex component CD14 (He et al., ).…”